Tc99m tilmanocept
Sponsors
Cardinal Health 414, LLC, Navidea Biopharmaceuticals
Conditions
MelanomaRhabdomyosarcomaRheumatoid ArthritisUterine Cervical Neoplasms
Phase 2
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
CompletedNCT02509598
Start: 2015-08-31End: 2019-03-06Updated: 2024-06-28
A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
TerminatedNCT02509585
Start: 2016-01-31End: 2017-07-31Updated: 2019-02-11
Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept
CompletedNCT04947137
Start: 2021-05-27End: 2022-01-21Updated: 2025-01-08